These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 21343401)
1. Activation of TYRO3/AXL tyrosine kinase receptors in thyroid cancer. Avilla E; Guarino V; Visciano C; Liotti F; Svelto M; Krishnamoorthy G; Franco R; Melillo RM Cancer Res; 2011 Mar; 71(5):1792-804. PubMed ID: 21343401 [TBL] [Abstract][Full Text] [Related]
2. Autocrine role for Gas6 with Tyro3 and Axl in leiomyosarcomas. el Sayadi H; Pissaloux D; Alberti L; Tabone-Eglinger S; Ranchere D; Decouvelaere AV; Tabone E; Ray-Coquard I; Caux C; Fayette J; Blay JY Target Oncol; 2013 Dec; 8(4):261-9. PubMed ID: 23354874 [TBL] [Abstract][Full Text] [Related]
3. Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival. Ammoun S; Provenzano L; Zhou L; Barczyk M; Evans K; Hilton DA; Hafizi S; Hanemann CO Oncogene; 2014 Jan; 33(3):336-46. PubMed ID: 23318455 [TBL] [Abstract][Full Text] [Related]
4. Hypoxia stabilizes GAS6/Axl signaling in metastatic prostate cancer. Mishra A; Wang J; Shiozawa Y; McGee S; Kim J; Jung Y; Joseph J; Berry JE; Havens A; Pienta KJ; Taichman RS Mol Cancer Res; 2012 Jun; 10(6):703-12. PubMed ID: 22516347 [TBL] [Abstract][Full Text] [Related]
5. Cross-phosphorylation, signaling and proliferative functions of the Tyro3 and Axl receptors in Rat2 cells. Brown JE; Krodel M; Pazos M; Lai C; Prieto AL PLoS One; 2012; 7(5):e36800. PubMed ID: 22606290 [TBL] [Abstract][Full Text] [Related]
6. Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma. Dantas-Barbosa C; Lesluyes T; Loarer FL; Chibon F; Treilleux I; Coindre JM; Meeus P; Brahmi M; Bally O; Ray-Coquard I; Sunyach MP; Cesne AL; Mir O; Bonvalot S; Toulmonde M; Italiano A; Saintigny P; Jean-Denis M; Ducimetiere F; Ranchere D; El Sayadi H; Alberti L; Blay JY Br J Cancer; 2017 Dec; 117(12):1787-1797. PubMed ID: 29024938 [TBL] [Abstract][Full Text] [Related]
7. Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells. Vouri M; An Q; Birt M; Pilkington GJ; Hafizi S Oncotarget; 2015 Jun; 6(18):16183-97. PubMed ID: 25980499 [TBL] [Abstract][Full Text] [Related]
8. The GAS6-AXL signaling pathway triggers actin remodeling that drives membrane ruffling, macropinocytosis, and cancer-cell invasion. Zdżalik-Bielecka D; Poświata A; Kozik K; Jastrzębski K; Schink KO; Brewińska-Olchowik M; Piwocka K; Stenmark H; Miączyńska M Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34244439 [TBL] [Abstract][Full Text] [Related]
9. TAM receptors Tyro3 and Mer as novel targets in colorectal cancer. Schmitz R; Valls AF; Yerbes R; von Richter S; Kahlert C; Loges S; Weitz J; Schneider M; Ruiz de Almodovar C; Ulrich A; Schmidt T Oncotarget; 2016 Aug; 7(35):56355-56370. PubMed ID: 27486820 [TBL] [Abstract][Full Text] [Related]
10. Tumor tissue and plasma levels of AXL and GAS6 before and after tyrosine kinase inhibitor treatment in EGFR-mutated non-small cell lung cancer. Nonagase Y; Takeda M; Azuma K; Hayashi H; Haratani K; Tanaka K; Yonesaka K; Ishii H; Hoshino T; Nakagawa K Thorac Cancer; 2019 Oct; 10(10):1928-1935. PubMed ID: 31419057 [TBL] [Abstract][Full Text] [Related]
11. Coexpression of growth arrest-specific gene 6 and receptor tyrosine kinases Axl and Sky in human uterine endometrial cancers. Sun WS; Fujimoto J; Tamaya T Ann Oncol; 2003 Jun; 14(6):898-906. PubMed ID: 12796028 [TBL] [Abstract][Full Text] [Related]
12. Up-regulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions. Weinger JG; Omari KM; Marsden K; Raine CS; Shafit-Zagardo B Am J Pathol; 2009 Jul; 175(1):283-93. PubMed ID: 19541935 [TBL] [Abstract][Full Text] [Related]
13. Expression of receptor-type tyrosine kinase, Axl, and its ligand, Gas6, in pediatric thyroid carcinomas around chernobyl. Ito M; Nakashima M; Nakayama T; Ohtsuru A; Nagayama Y; Takamura N; Demedchik EP; Sekine I; Yamashita S Thyroid; 2002 Nov; 12(11):971-5. PubMed ID: 12490074 [TBL] [Abstract][Full Text] [Related]
14. A promiscuous liaison between IL-15 receptor and Axl receptor tyrosine kinase in cell death control. Budagian V; Bulanova E; Orinska Z; Thon L; Mamat U; Bellosta P; Basilico C; Adam D; Paus R; Bulfone-Paus S EMBO J; 2005 Dec; 24(24):4260-70. PubMed ID: 16308569 [TBL] [Abstract][Full Text] [Related]
15. Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor. Sainaghi PP; Castello L; Bergamasco L; Galletti M; Bellosta P; Avanzi GC J Cell Physiol; 2005 Jul; 204(1):36-44. PubMed ID: 15605394 [TBL] [Abstract][Full Text] [Related]
16. AXL is an oncotarget in human colorectal cancer. Martinelli E; Martini G; Cardone C; Troiani T; Liguori G; Vitagliano D; Napolitano S; Morgillo F; Rinaldi B; Melillo RM; Liotti F; Nappi A; Bianco R; Berrino L; Ciuffreda LP; Ciardiello D; Iaffaioli V; Botti G; Ferraiolo F; Ciardiello F Oncotarget; 2015 Sep; 6(27):23281-96. PubMed ID: 25966280 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of Axl and Gas6 in renal cell carcinoma reflecting tumor advancement and survival. Gustafsson A; Martuszewska D; Johansson M; Ekman C; Hafizi S; Ljungberg B; Dahlbäck B Clin Cancer Res; 2009 Jul; 15(14):4742-9. PubMed ID: 19567592 [TBL] [Abstract][Full Text] [Related]
18. Akt is required for Axl-Gas6 signaling to protect cells from E1A-mediated apoptosis. Lee WP; Wen Y; Varnum B; Hung MC Oncogene; 2002 Jan; 21(3):329-36. PubMed ID: 11821945 [TBL] [Abstract][Full Text] [Related]
19. Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stroma. Ben-Batalla I; Schultze A; Wroblewski M; Erdmann R; Heuser M; Waizenegger JS; Riecken K; Binder M; Schewe D; Sawall S; Witzke V; Cubas-Cordova M; Janning M; Wellbrock J; Fehse B; Hagel C; Krauter J; Ganser A; Lorens JB; Fiedler W; Carmeliet P; Pantel K; Bokemeyer C; Loges S Blood; 2013 Oct; 122(14):2443-52. PubMed ID: 23982172 [TBL] [Abstract][Full Text] [Related]